PPARG and type 2 diabetes mellitus: It is worth noting that targeting the downstream effect of ectopic/visceral fat accumulation, i.e., chronic/meta-inflammation, might favor PPARγ-associated adiposity and bring no apparent metabolic benefits to patients with T2DM [23].